Excellent
Aligned
Patient Risk:
Low
Summary
All extracted claims are supported by the provided FDA label text, specifically the 6.2 Postmarketing Experience section listing dizziness and additional neurologic-related adverse reactions.
Category Scores
Accurate Statements
Atorvastatin (Lipitor) can cause dizziness.
Label (6.2 Postmarketing Experience) lists "dizziness" among postmarketing adverse reactions.
Product safety information includes dizziness among potential side effects of atorvastatin (Lipitor).
Label (6.2 Postmarketing Experience) lists "dizziness" among postmarketing adverse reactions.
Lipitor’s safety information includes other neurologic-related effects besides dizziness.
Label (6.2 Postmarketing Experience) lists "memory impairment, depression, and peripheral neuropathy" along with "dizziness" (all neurologic-related).
Unsupported Statements
Contradictions
Important Omissions
Safety Assessment
Potential Patient Risk:
Low
Claims are limited to adverse reaction presence (dizziness and other neurologic-related postmarketing adverse reactions) and do not include dosing, contraindications, or instructions that could create unsafe use based on the provided label excerpts.
Regulatory Assessment
| On Label |
Yes |
| Off-label Discussion |
No |
| Promotes Unapproved Use |
No |
| Hallucination Risk |
Low |
Recommendation
Aligned
Primary Issue
Suggested Improvement